Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teja Celhar

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|December 26, 2016
Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesTeja Celhar, Anna-Marie Fairhurst
Frontiers in Pharmacology|December 25, 2014
Toll-like receptors in systemic lupus erythematosus: potential for personalized treatmentTeja Celhar, Anna-Marie Fairhurst
Prostaglandins & Other Lipid Mediators|May 24, 2011
Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cellsMatevz Prijatelj, Teja Celhar, Irena Mlinaric-Rascan
Current Protocols|November 8, 2021
Assessing Lupus-Like Disease in Murine Model SystemsHui Yin Lee, Teja Celhar, Anna-Marie Fairhurst
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2020
Low-Density Neutrophils in Systemic Lupus ErythematosusSen Hee Tay, Teja Celhar, Anna-Marie Fairhurst
The Journal of Pharmacy and Pharmacology|July 11, 2012
EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathwaysMatevz Prijatelj, Teja Celhar, Martina Gobec, et al.
Cancer Genetics and Cytogenetics|November 11, 2008
The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancerTeja Celhar, Ksenija Gersak, Zdenka Ovcak, et al.
Rheumatology (Oxford, England)|April 5, 2017
Pathways leading to an immunological disease: systemic lupus erythematosusOlga Zharkova, Teja Celhar, Petra D Cravens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2013
The exonuclease Trex1 restrains macrophage proinflammatory activationSelma Pereira-Lopes, Teja Celhar, Gloria Sans-Fons, et al.
European Journal of Pharmacology|November 27, 2008
Azaphenylalanine-based serine protease inhibitors induce caspase-mediated apoptosisTeja Celhar, Tina Batista Napotnik, Ales Obreza, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|December 26, 2016
Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesTeja Celhar, Anna-Marie Fairhurst
Frontiers in Pharmacology|December 25, 2014
Toll-like receptors in systemic lupus erythematosus: potential for personalized treatmentTeja Celhar, Anna-Marie Fairhurst
Prostaglandins & Other Lipid Mediators|May 24, 2011
Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cellsMatevz Prijatelj, Teja Celhar, Irena Mlinaric-Rascan
Current Protocols|November 8, 2021
Assessing Lupus-Like Disease in Murine Model SystemsHui Yin Lee, Teja Celhar, Anna-Marie Fairhurst
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2020
Low-Density Neutrophils in Systemic Lupus ErythematosusSen Hee Tay, Teja Celhar, Anna-Marie Fairhurst
The Journal of Pharmacy and Pharmacology|July 11, 2012
EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathwaysMatevz Prijatelj, Teja Celhar, Martina Gobec, et al.
Cancer Genetics and Cytogenetics|November 11, 2008
The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancerTeja Celhar, Ksenija Gersak, Zdenka Ovcak, et al.
Rheumatology (Oxford, England)|April 5, 2017
Pathways leading to an immunological disease: systemic lupus erythematosusOlga Zharkova, Teja Celhar, Petra D Cravens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2013
The exonuclease Trex1 restrains macrophage proinflammatory activationSelma Pereira-Lopes, Teja Celhar, Gloria Sans-Fons, et al.
European Journal of Pharmacology|November 27, 2008
Azaphenylalanine-based serine protease inhibitors induce caspase-mediated apoptosisTeja Celhar, Tina Batista Napotnik, Ales Obreza, et al.
Pageof 2